Dermocosmetic Market Ripens With Uptake Of FDA-Approved Drug Ingredients
This article was originally published in The Rose Sheet
Executive Summary
The market for specialized dermocosmetics is expanding rapidly as big beauty marketers join the fray with products containing OTC-approved drug ingredients for hair and skin care, says Euromonitor Beauty & Personal Care analyst Nicholas Micallef. Coal tar, ketoconazole and salicylic acid are among approved drug ingredients increasingly making their way into beauty.
You may also be interested in...
P&G’s NIOXIN Shows How To Address Hair Loss Without An FDA Warning
With FDA scrutinizing the marketplace for cosmetics promoted as drugs, and a clear cautionary statement from the agency about topical products marketed as hair growers or hair-loss preventers, beauty firms have little choice but to incorporate approved OTC drug ingredients in such products. P&G’s professional hair-care brand NIOXIN has done just that with its new Advanced Thinning range featuring minoxidil.
Can Premium Hair Care Match Skin-Care Growth Trajectory?
Euromonitor senior beauty analyst Oru Mohiuddin considers premium hair care’s prospects for realizing growth on par with premium skin care in recent years. Factors that may impede the category’s growth at the same level as skin care include differences in consumer perception and regulatory restrictions.
J&J Pits 5% Minoxidil Rogaine For Women Against ‘Cosmetic, Quick Fixes’
Firm’s McNeil-PPC subsidiary has patent exclusivity for Women’s Rogaine with the higher concentration of minoxidil through February 2017, tightening its grip on a market that cosmetics firms have struggled to penetrate effectively in the United States. According to a brand consultant and dermatologist, the new Rogaine offering actually helps regrow hair rather than merely “masking” the issue.